Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

InVivoMAb Anti-Influenza A virus(A/Singapore/H2011.447/2011(H3N2)) HA/Hemagglutinin Broadly Neutralizing Antibody (F045-092)


View Antibody details

InVivoMAb Anti-Influenza A virus(strain A/Brevig Mission/1/1918 H1N1) (strain A/South Carolina/1/1918 H1N1)) HA/Hemagglutinin Antibody (Iv0149)


View Antibody details

InVivoMAb Anti-Influenza A virus(strain A/Japan/305/1957 H2N2) Neuraminidase/NA Antibody (1E01#)


View Antibody details

InVivoMAb Anti-Influenza A virus(strain A/Swine/New Jersey/11/1976 H1N1) HA/Hemagglutinin Antibody (Iv0146)


View Antibody details

InVivoMAb Anti-Influenza B virus(strain B/Lee/1940) NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17)


View Antibody details

InVivoMAb Anti-Influenza B virus(strain B/Maryland/1959) HA/Hemagglutinin Antibody (Iv0147)


View Antibody details

InVivoMAb Anti-JEV Envelope protein E Antibody (2F2)


View Antibody details

InVivoMAb Anti-JUNV GP1 glycoprotein Antibody (JUN1#)


View Antibody details

InVivoMAb Anti-LASV GPC Antibody (LAVA01)


View Antibody details

InVivoMAb Anti-MACV GP1 glycoprotein Antibody (MAC1)


View Antibody details